← Back to Analyst Consensus 
VERA Buy
Vera Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 20
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | Leerink Partners | initiate | — → Market Perform | — | 51% |
| Sep 8, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 17, 2026 | Wedbush | reiterate | Neutral → Neutral | — | 58% |
| Aug 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 11, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Jul 8, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 8, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 8, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Jul 8, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 7, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| May 15, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 11, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | — | 53% |
| Mar 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Dec 19, 2025 | B of A Securities | maintain | Buy → Buy | $66 | 53% |
| Dec 19, 2025 | Goldman Sachs | maintain | Buy → Buy | $95 | 54% |
| Dec 19, 2025 | JP Morgan | maintain | Overweight → Overweight | $96 | 54% |
| Dec 11, 2025 | Wedbush | maintain | Neutral → Neutral | $33 | 58% |
| Dec 8, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $97 | 58% |
| Dec 5, 2025 | TD Cowen | maintain | Buy → Buy | $73 | 54% |
| Nov 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $90 | 44% |
| Nov 7, 2025 | JP Morgan | maintain | Overweight → Overweight | $52 | 54% |
| Oct 16, 2025 | B of A Securities | initiate | — → Buy | $48 | 53% |
| Aug 7, 2025 | JP Morgan | maintain | Overweight → Overweight | $53 | 54% |
| Aug 4, 2025 | Wolfe Research | downgrade | Outperform → Peer Perform | $0 | 53% |
| Jun 2, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $65 | 55% |
| Jun 2, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $85 | 44% |
| May 12, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $55 | 55% |
| May 7, 2025 | Wedbush | maintain | Neutral → Neutral | $26 | 58% |
| May 7, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $100 | 50% |
| Mar 4, 2025 | JP Morgan | maintain | Overweight → Overweight | $71 | 54% |
| Feb 27, 2025 | Guggenheim | maintain | Buy → Buy | $61 | 52% |
| Feb 4, 2025 | Wolfe Research | initiate | — → Outperform | $49 | 53% |
| Nov 21, 2024 | Wells Fargo | initiate | — → Overweight | $70 | 54% |
| Nov 8, 2024 | Wedbush | maintain | Neutral → Neutral | $38 | 58% |
| Nov 5, 2024 | JP Morgan | maintain | Overweight → Overweight | $75 | 54% |
| Oct 28, 2024 | Guggenheim | maintain | Buy → Buy | $64 | 52% |
| Oct 16, 2024 | Scotiabank | initiate | — → Sector Outperform | $60 | 55% |
| Oct 3, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $107 | 50% |
| Oct 1, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $107 | 50% |
| Sep 23, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $107 | 50% |
| Sep 16, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $107 | 50% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $107 | 50% |
| Sep 6, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $107 | 50% |
| Sep 3, 2024 | JP Morgan | maintain | Overweight → Overweight | $72 | 54% |
| Aug 13, 2024 | JP Morgan | maintain | Overweight → Overweight | $62 | 54% |
| May 31, 2024 | JP Morgan | maintain | Overweight → Overweight | $65 | 54% |
| May 10, 2024 | Raymond James | maintain | Strong Buy → Strong Buy | $68 | 54% |
| Apr 5, 2024 | Guggenheim | reiterate | Buy → Buy | $56 | 52% |
| Mar 27, 2024 | Guggenheim | maintain | Buy → Buy | $56 | 52% |
| Mar 21, 2024 | Wedbush | maintain | Neutral → Neutral | $34 | 58% |
Price Target Trend
Jun 21, 2026 Latest: $74.2 Oct 25, 2026
EPS Estimates
0y $-6.25
Lo: $-7.23 Hi: $-5.77
10 analysts +1q $-1.54
Lo: $-2.18 Hi: $-1.21
9 analysts 0q $-1.61
Lo: $-1.80 Hi: $-1.39
9 analysts ▲1
+1y $-4.25
Lo: $-6.72 Hi: $-2.23
10 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days